Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
 |
Results for 'Cardiovascular Drug Delivery' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
The Top 100 Drug Delivery Companies Worldwide |
January 2004 | £545 | 37 % |
|
Drug Delivery Technology: Revolutionizing Cardiovascular Therapies |
July 2007 | £945 | 35 % |
|
Chronotherapeutics |
September 2003 | £75 | 34.65 % |
|
Drug Delivery Systems US Market Outlook, Advances for Pharma, Biotech & Medical Devices |
September 2006 | £1400 | 31.85 % |
|
Advanced Drug Delivery Systems: New Developments, New Technologies |
October 2006 | £2960 | 31.5 % |
|
Nanotechnology in Health Care to 2009 |
May 2005 | £2560 | 30.8 % |
|
BioChips & BioMEMS (Bio Microelectromechanical Systems) World Markets, Applications & Opportunities 2006-2011 Analysis & Forecasts |
May 2006 | £1095 | 29.5 % |
|
Textbook of Interventional Cardiovascular Pharmacology |
April 2007 | £140 | 29.4 % |
|
Future of the Medical Equipment Industry |
May 2008 | £2135 | 29.4 % |
|
Stakeholder Opinions Novel Therapeutic Approaches in Cardiovascular Medicine - Lack of Market Prospects for Biologics Expose An Opportunity for Cell and Gene Therapies |
July 2008 | £3800 | 27.65 % |
|
Medical Equipment M&A Trends November 2008 |
November 2008 | £610 | 26.95 % |
|
Cardiovascular Drug Delivery Technologies,Markets and Companies |
May 2009 | £1525 | 26.6 % |
|
Medical Equipment Mergers & Acquisitions Trends - April 2009 |
April 2009 | £610 | 26.25 % |
|
Medical Equipment Mergers & Acquisitions Trends – May 2009 |
May 2009 | £610 | 26.25 % |
|
Medical Equipment M&A Trends December 2008 |
December 2008 | £410 | 26.25 % |
|
Dermatological and Cosmeceutical Development: Absorption Efficacy and Toxicity |
August 2007 | £130 | 25.9 % |
|
Mergers & Acquisitions and Financing Trends in Medical Equipment, 2008 |
March 2009 | £2135 | 25.55 % |
|
Arrow International, Inc. Medical Equipment Company Report Medical Device Company Analysis Covering key Information Relating to Company Market Share by Sector and Country, Financial, SWOT and Value Chain Analysis |
April 2008 | £310 | 25.2 % |
|
Transdermal Drug Delivery Technologies, Markets and Companies |
May 2009 | £1525 | 24.85 % |
|
Nanotoxicology: Characterization, Dosing and Health Effects |
July 2007 | £432 | 24.15 % |
|
The Cardiovascular Disorders Market Outlook to 2012 |
February 2008 | £1995 | 23.8 % |
|
Mergers & Acquisitions and Financing Trends in Medical Equipment Q1 2009 |
April 2009 | £915 | 23.8 % |
|
Partneringreview 2006 |
February 2006 | £2195 | 23.8 % |
|
Medical Weekly Deals Summaries 01 June 2009 |
June 2009 | £76 | 23.45 % |
|
Medical Equipment M&A Trend-August 2008 |
August 2008 | £610 | 23.45 % |
|
Medical Equipment M&A Trends - October 2008 |
October 2008 | £610 | 23.45 % |
|
Medical Equipment M&A Trends - July 2008 |
July 2008 | £610 | 23.1 % |
|
Medical Equipment M&A Trends - September 2008 |
September 2008 | £610 | 23.1 % |
|
Medical Equipment M&A Trends - May 2008 |
May 2008 | £610 | 23.1 % |
|
United Kingdom Medical Equipment Markets Investment Opportunities, Analysis and Forecasts in Medical Devices to 2012 |
March 2009 | £1220 | 23.1 % |
|
Nanotechnology Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics |
January 2008 | £1995 | 22.75 % |
|
Executive Summary of the BioChips & BioMEMS (Biomedical Microelectromechanical Systems) Markets 2006-2011 Analysis & Forecasts |
May 2006 | £670 | 22.5 % |
|
Pipeline Insight: Insulins Inhalable insulins unlikely to become blockbusters |
September 2006 | £6000 | 21.7 % |
|
Pharmaceutical Contract Manufacturing and Research |
May 2005 | £2960 | 21.7 % |
|
The Future of Targeted Therapeutics Key Technologies, New Therapy Area Applications and Leading Players |
March 2008 | £1995 | 21.35 % |
|
RNA Interference for Drug R&D Applications, Alliances, Companies and WW Market to 2011 |
July 2007 | £1585 | 21 % |
|
Generic Drug Market in Canada |
February 2008 | £855 | 21 % |
|
United States Medical Equipment Market Analysis & Forecasts to 2015 |
March 2009 | £2440 | 20.65 % |
|
United States Medical Equipment Market Analysis & Forecasts to 2015 |
March 2009 | £2440 | 20.65 % |
|
Medical Weekly Deals Summaries 01 April 2009 |
April 2009 | £76 | 20.65 % |
|
United States Medical Equipment Markets Investment Opportunities, Analysis and Forecasts in Medical Devices to 2012 |
December 2008 | £1220 | 20.3 % |
|
eSampling Strategies Using Internet Technologies to Increase Impact at the Point of Care |
October 2006 | £2005 | 19.95 % |
|
Contract Pharmaceutical Manufacturing, Research, and Packaging |
August 2007 | £2960 | 19.6 % |
|
Top 10 Medical Equipment Trends in 2009 |
December 2008 | £2135 | 19.6 % |
|
Specialty Pharma Market Outlook, The Key players, new company growth models and emerging opportunities |
October 2006 | £1495 | 19.25 % |
|
Top 10 Medical Equipment Market Trends |
May 2008 | £2135 | 19.25 % |
|
United States Medical Equipment Markets Investment Opportunities, Analysis and Forecasts in Medical Devices to 2012 |
May 2008 | £1220 | 18.55 % |
|
Diabetes Drug Discoveries 2009: what the future holds |
February 2009 | £795 | 18.55 % |
|
Pipeline Insight: Insulin Antidiabetics Return to Injections Alternative Delivery Methods Fall by The Wayside |
July 2008 | £6000 | 18.55 % |
|
United States Medical Equipment Markets: Investment Opportunities, Analysis and Forecasts in Medical Devices to 2012 |
May 2008 | £1220 | 18.55 % |
|
Cordis Corporation Medical Equipment Company Share Analysis |
October 2008 | £610 | 17.5 % |
|
Biovail Corp - Financial and Strategic Analysis Review |
June 2009 | £76 | 17 % |
|
AorTech International plc - Financial and Strategic Analysis Review |
June 2009 | £76 | 17 % |
|
Innovations in The Management of Diabetes Next generation treatments and market dynamics |
June 2008 | £1995 | 17 % |
|
Inyx, Inc. - Financial and Strategic Analysis Review |
April 2009 | £76 | 16.5 % |
|
Boston Scientific Corporation Product Pipeline Analysis |
August 2008 | £460 | 16.45 % |
|
Stakeholder Opinion: Erectile Dysfunction Identifying product differentiation and patient segmentation strategies |
December 2006 | £2005 | 16.45 % |
|
Biocompatible Materials for the Human Body |
March 2007 | £2960 | 16.1 % |
|
Royalty Financing Agreements in Pharma, Biotech and Diagnostics |
January 2009 | £495 | 16.1 % |
|
Gene Therapy Technologies, Markets and Companies |
May 2009 | £2440 | 16 % |
|
RNAi Technologies, Markets and Companies |
May 2009 | £1830 | 15.4 % |
|
Scrip Yearbook 2007 23rd Edition (2 Volumes) |
January 2006 | £895 | 15.4 % |
|
Forecast of the Key Pipeline Devices to Impact the Medical Equipment Market by 2012 |
December 2008 | £2135 | 15.4 % |
|
The Future of Monoclonal Antibodies Therapeutics Innovation in antibody engineering, key growth strategies and forecasts to 2011 |
July 2006 | £1495 | 15.05 % |
|
World Diabetes Market Analysis 2009-2023 |
February 2009 | £1499 | 14.7 % |
|
Outlook for RNAi, 2007 siRNA and miRNA in biology, diagnostics and therapeutics |
June 2007 | £1495 | 14.7 % |
|
Market for Bioengineered Protein Drugs; The |
January 2007 | £2960 | 14.35 % |
|
Diabetes Therapies & Diagnostics: Global Markets |
January 2008 | £2960 | 14 % |
|
Global Cardiovascular Device Markets 2007-2012 |
January 2007 | £1875 | 13.65 % |
|
Pipeline Insight: Non-insulin Antidiabetics Type 2 diabetes unlikely to develop into a switch market |
August 2006 | £6495 | 13.3 % |
|
Licensing Strategies - Examining Todays Pharmaceutical Licensing Trends |
November 2007 | £7600 | 12.95 % |
|
DePuy Medical Device Company Intelligence Report |
December 2007 | £295 | 12.95 % |
|
Takeda: Pipeline, Products, Performance, Potential |
November 2007 | £595 | 12.95 % |
|
Modern Biopharmaceuticals Design, Development and Optimization, 4 Volumes |
September 2005 | £440 | 12.6 % |
|
The World Market for Gynaecology 2007-2017 |
September 2007 | £3200 | 12.6 % |
|
Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts: The Challenge Of Turning Technology Into Therapy |
July 2007 | £1999 | 12.25 % |
|
Cordis Medical Device Company Intelligence Report |
November 2007 | £295 | 12.25 % |
|
Medical Weekly Deals Summaries 06 April 2009 |
April 2009 | £76 | 12.25 % |
|
Manufacturing & Supply Agreements in Biopharma |
April 2008 | £1195 | 12.25 % |
|
Global Protein Therapeutics Market Analysis |
September 2007 | £1100 | 12.25 % |
|
Diabetes, Metabolic Syndrome and Cardiovascular Disease Reshaping Tomorrow's Diabetes Market |
October 2005 | £1220 | 11.9 % |
|
Medical Weekly Deals Summaries 20 April 2009 |
April 2009 | £76 | 11.9 % |
|
Nitric Oxide Therapeutics, Markets and Companies |
May 2009 | £1710 | 11.55 % |
|
Co-Promotion & Co-Marketing Agreements in Pharma, Biotech and Diagnostics |
February 2009 | £1195 | 11.55 % |
|
Future of RNAi Therapeutics, The Drug Pipelines and Prospects |
September 2008 | £1995 | 10.85 % |
|
Cell Therapy Technologies, Markets and Companies |
May 2009 | £2745 | 10.5 % |
|
Medical Weekly Deals Summaries 13 April 2009 |
April 2009 | £76 | 10.5 % |
|
Commercial Insight: Pain Market Overview Non-Traditional Analgesics and Opioid Reformulations to Sustain Sector Growth |
October 2008 | £8000 | 10.5 % |
|
Cordis Corporation Product Pipeline Analysis |
August 2008 | £460 | 10.15 % |
|
Medical Device Coatings |
November 2008 | £2960 | 10.15 % |
|
Cell Therapy Markets |
July 2007 | £2075 | 9.8 % |
|
Commercial and Pipeline Insight: HRT for Menopausal Symptoms A new class restores an old market |
April 2008 | £8000 | 9.8 % |
|
How Drugs Are Developed 3rd Edition |
January 2007 | £1095 | 9.8 % |
|
Pain Therapeutics Drugs, Markets and Companies |
May 2009 | £1830 | 9.8 % |
|
Immunomodulators Therapeutic Needs, Pipelines & Prospects |
August 2007 | £1495 | 9.45 % |
|
Stem Cell Therapies and Regenerative Medicine Current Applications and Future Possibilities |
December 2005 | £2960 | 9.45 % |
|
Clinical Trials Business; The |
August 2006 | £2960 | 9.45 % |
|
Medical Weekly Deals Summaries 25 May 2009 |
May 2009 | £76 | 9.45 % |
|
World Diabetes Market, The 2005-2011 |
March 2006 | £1499 | 9.1 % |
|
Medical Weekly Deals Summaries 18 May 2009 |
May 2009 | £76 | 8.75 % |
|
Cook Medical Product Pipeline Analysis |
August 2008 | £460 | 8.75 % |
|
Personalized Medicine Scientific & Commercial Aspects |
May 2009 | £2440 | 8.4 % |
|
Partneringreview 2006 – Industry Sector Volume 6 |
February 2006 | £1395 | 8 % |
|
Biomarkers The Expanding Global Market |
November 2007 | £2960 | 7.7 % |
|
Pipeline Insight: Parkinson's Disease and Restless Legs Syndrome Reformulations set to drive near-term growth |
August 2006 | £8695 | 7.7 % |
|
Cardiovascular Catherers and Systems |
January 2007 | £2350 | 7.35 % |
|
Medtronic Medical Device Company Intelligence Report |
September 2006 | £495 | 6.65 % |
|
Smiths Medical Medical Equipment Company Share Analysis |
September 2008 | £610 | 6.65 % |
|
The Executive Guide to Molecular Imaging |
July 2007 | £595 | 5.6 % |
|
Monoclonal Antibodies Report |
June 2008 | £3800 | 5.25 % |
